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Objective(s): Jervell and Lange–Nielsen syndrome is an autosomal recessive disorder caused by 
mutations in KCNQ1 or KCNE1 genes. The disease is characterized by sensorineural hearing loss and 
long QT syndrome. 
Materials and  Methods Here we present a 3.5-year-old female patient, an offspring of consanguineous 
marriage, who had a history of recurrent syncope and congenital sensorineural deafness. The patient 
and the family members were screened for mutations in KCNQ1 gene by linkage analysis and DNA 
sequencing. 
Results: DNA sequencing showed a c.1532_1534delG (p. A512Pfs*81) mutation in the KCNQ1 gene in 
homozygous form. The results of short tandem repeat (STR) markers showed that the disease in the 
family is linked to the KCNQ1 gene. The mutation was confirmed in the parents in heterozygous form. 
Conclusion: This is the first report of this variant in KCNQ1 gene in an Iranian family. The data of this 
study could be used for early diagnosis of the condition in the family and genetic counseling. 
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Introduction 
Jervell and Lange–Nielsen syndrome (JLNS) is a     
rare autosomal recessive disease (OMIM# 220400) 
characterized by congenital sensorineural deafness and 
significant QT interval prolongation often more than 
500 msec in the electrocardiogram. The patients with 
long QT syndrome (LQTS) are prone to polymorphic 
ventricular arrhythmias, syncope, and sudden death 
(1). At least, 16 genes have been reported causing 
autosomal-dominant Romano-Ward syndrome (RWS) 
and two genes as the cause of JLNS (2). Mutations in 
KCNQ1, KCNH2, and SCN5A genes constitute more than 
75% of pathogenic alleles in LQTS (3, 4). 
Homozygous or compound heterozygous mutations 
in the KCNQ1 gene and less frequently in the KCNE1 
gene lead to JLNS (5, 6). The α- and β-subunits of the 
potassium ion channel, which transport potassium 
actively out of the cardiac and inner ear cells, are 
encoded by KCNQ1 and KCNE1 genes, respectively (7). 
QT intervals in patients with KCNQ1 mutations (90% of 
the cases) are longer than those with KCNE1 mutations, 
 
and the risk of arrhythmic events is also higher in these 
patients (8). In homozygous patients with JLNS, 
potassium transport is also affected in the inner ear 
cells, which causes sensorineural hearing loss. Usually, 
JLNS heterozygous carriers are asymptomatic; 
however, they might have mild QT prolongation 
without deafness. 
In this report, a female patient clinically diagnosed 
JLNS is described, and molecular assays were then 
performed for confirming the diagnosis. 
 
Methods 
Case Report 
A 3.5-year-old girl was referred to our emergency 
unit at the Rajaei’s Cardiovascular Medical and Research 
Center (Tehran-Iran) due to syncope. 
The medical history showed recurrent syncope and 
deafness and the history of bradycardia during the fetal 
period. The patient’s first syncopal episode occurred at 
the age of 18 months. Cochlear implantation had been 
performed at age 2. There was no family history of 
convulsions or sudden cardiac death in three generations.  
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Figure 1. The Pedigree of the family (A): proband is shown with a black filled circle and an arrow head. Half filled squares or circles denote 
heterozygotes for KCNQ1 gene mutation, transmitted from parents (other family members have not been studuied), and ECG of the patient (B): 
demonstrating prolonged QTc interval (581 msec) 
 
In addition, the patient was the offspring of a first-degree 
consanguineous marriage (Figure 1-A). Her mother reported 
one stillbirth in the previous pregnancy. 
No abnormalities except for hearing impairment were 
detected during physical and neurological examinations. 
In the para-clinical studies, routine tests, the level of 
electrolytes and hormones was normal. Resting 12-lead 
electrocardiogram (ECG) exhibited a markedly prolonged 
QTc interval of more than 580 msec (corrected with 
Bazzet’s formula) and T wave alternans (Figure 1-B). 
Also, a structurally normal heart was detected by 
echocardiography.  
Propranolol with the dose of 3 mg/kg/day, divided 
into three daily doses, and started for the patient. 
Because of the high-risk situation, an endocardial single 
chamber implantable cardioverter defibrillator (ICD) 
was implanted. Thereafter, the patient was event-free 
and followed up for 16 months. The ECGs recorded 
from the father (QTc = 427 msec) and the mother (QTc 
= 461 msec) (data not shown) were normal (normal 
range <440-460 msec).  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
Genetic study 
The blood samples were collected in tubes containing 
EDTA from the patient, parents and available family 
members. After obtaining written informed consent, 
genomic DNA was extracted from peripheral blood 
leukocytes using the salting-out method (9). For 
detecting the related genes in such heterogeneous 
cardiac diseases, twelve short tandem repeat (STR) 
markers (D11SD8.3, D11SU10.9, D11SU2.2, D11SU0.6, 
D11SD13.6, D11SI, D21SU10, D21SU1.1, D21SD13, 
D21SD22, D21SD23, D21SD28) within or surrounding 
the KCNQ1 and KCNE1 genes were selected and 
amplified for the family members. Size determination of 
the repeats was performed on ABI 3130XL Genetic 
Analyzer (Applied Biosystems, Foster City, CA).  Primers 
were designed for coding exons and flanking exon-
intron boundaries encompassing splice sites of KCNQ1 
[NM_000218] gene (primers are available upon 
request). For exon 12, the following primers were used:  
(forward primer: 5ʹ- GGACATGGCCTAAGTATCTCC-3ʹ, 
reverse primer: 5ʹ- CCTATCTGAGACCTGACAGTGC-3ʹ). 
PCR amplification was carried out in a 25-μl reaction 
volume containing 3.2 mM dNTP, 2.5 µl 10X Buffer, 2 
mM MgCl2, 0.5 unit/µl SmarTaq DNA Polymerase 
(Cinaclon, Iran) and 200 ng of genomic DNA. PCR 
amplification was performed in PCR Master Cycler 
(Eppendorf, Germany) with the following thermal 
conditions:  95 °C for 5 min, thirty-five cycles in 95 °C for 
90 sec, 62 °C for 90 sec, 72 °C for 40 sec and final  
extension at 72 °C for 10 min. The amplicons were 
directly sequenced bidirectionaly on ABI 3130XL 
Genetic Analyzer by Kawsar Biotech Co. (KBC, Tehran, 
Iran) (10). The sequencing data were aligned against 
the RefSeq genomic accession number (NG_008935.1). 
The variants were compared with the database of 
mutations in KCNQ1 gene:  
(http://www.genomed.org/lovd2/home.php) 
 
Results  
STR markers results showed that the disease in the 
family is linked to the KCNQ1 gene (data not shown). 
Bidirectional Sanger Sequencing of the KCNQ1 gene for 
the patient revealed a novel frameshift mutation 
c.1532_1534delG (p. A512Pfs*81) (ClinVar accession 
number: SCV000584010) in homozygous form (Figure. 
2). This 1-bp deletion in exon 12 results in a premature 
stop codon at residue 592. True homozygosity was 
confirmed by parental testing; parents were both 
heterozygous for the mutation (Figure 2). The mutation 
has not been reported in the literature and KCNQ1 gene 
mutation database previously.   
 
Discussion 
JLNS, an autosomal recessive form of LQTS, is 
characterized by congenital bilateral hearing loss and 
prolonged QT interval (1, 11, 12). JLNS patient in this  
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Figure 2. Sanger sequencing results of KCNQ1 gene: Arrows show 
the location of c.1532_1534delG (p. A512Pfs*81) mutation in the 
heterozygous parent and the homozygous patient compared with 
the normal control 
 
family had homozygous frameshift mutation (c.1532_ 
1534delG) in the KCNQ1 gene with a QTc≥580 msec 
experience of cardiac arrhythmias and repeated 
syncopal event. Although the electrophysiological study 
was not performed in this case, the reported frameshift 
mutation was predicted to have a pathogenic effect 
with an estimated predicted value (EPV) of 99% (6). 
Neyroud et al. (1999) (13) described an insertion of a 
cytosine at position 1893 (1893insC) in exon 15 in a 
LQT family that led to disruption in the C-terminus 
coding region of the gene. It is expected that the 
truncated protein caused by the frameshift mutation in 
the exon 12 causes a severe form of the disease. 
Moreover, it might cause substantial structural changes 
in the encoded potassium channel subunits, which is 
likely to severely reduce or abolish the channel function. 
Also in a report in 2003 (14), a single nucleotide C 
insertion, c.1338insC, leading to a premature stop codon 
and truncation of the KCNQ1 C-terminus was characterized 
in a LQT patient who died suddenly while swimming at 
the age 11. The frameshift mutations in KCNQ1 have 
also been reported as protein truncating (15) in which 
the loss of the C- terminus part of the protein in 
truncating form prevents the formation of tetramer from 
monomers and likewise, it was suggested that 
truncating mutations resulted in the loss of function 
(16). Furthermore, Qureshi et al. (2013) described 
prediction of the protein secondary structure in 
comparison with the wild-type protein and revealed 
that 1- nucleotide deletion of a ‘G’ (2592597delG) 
(G216Afs*21) in exon 4 led to altered secondary 
structure and subsequently diminution of the protein 
strands production (17). There are challenges about 
phenotype correlation of RWS or JLNS to the type of 
mutation (missense, nonsense, frameshift, etc.) in 
KCNQ1 gene. RWS with a dominant-negative effect on 
the tetrameric KCNQ1 channel is usually induced by 
missense variants, whereas nonsense and frameshift 
mutations tend to cause autosomal recessive JLNS (15). 
However, exceptions exist in which JLNS could also be 
caused by missense mutations (5). In JLNS patients, QTc 
prolongation is much more than in any other LQTS 
patients, which is probably related to the presence of 
mutations in two alleles (8). Our patient with a 
homozygous frameshift mutation displayed the prolonged 
QT interval, the clinical manifestations of T-wave 
alterations and multiple episodes of syncope.  
Unexpectedly, the R518X mutation in exon 12 of 
KCNQ1 gene was found in association with LQTS 
without deafness (18). The absence of hearing loss 
symptom in the presence of mutations in KCNQ1 gene 
may cause misdiagnosis of JLN syndrome. 
As many of these patients are referred to the 
audiologist, ENT specialist, speech therapist or general 
practitioner, the education of healthcare providers 
about the possibility of the underlying cardiac disease 
may lead to earlier diagnosis of JLNS. Among children 
with JLNS, who are not treated, more than half die prior 
to age 15 (9, 19). Given the poor prognosis of long QT 
syndrome when it presents in combination with 
sensorineural deafness, an ICD was implanted in our 
patient shortly after diagnosis. In addition, she was in 
the high-risk group of JLNS patients due to a history of 
early childhood syncope, a longer QT interval (>580 
msec) and a detected mutation in KCNQ1. Correct 
diagnosis allows preventive actions, including β-blockade, 
reduction of physical and emotional stress, avoidance of 
QT-prolonging drugs, and implantation of an ICD.  
 
Conclusion  
This study is the first report of a novel mutation in 
the KCNQ1 gene causal to JLNS in an Iranian family. Its 
implication as a diagnostic tool in the clinical setting and 
in genetic counseling has been discussed. Our results 
suggest that evaluation of all sensory neural deafness 
children should be completed by ECG and very careful 
medical history. In cases with JLNS, genetic analysis 
could help us to predict prognosis of arrhythmia.  
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